| Primary gastric lymphoma, epidemiology, clinical diagnosis, and treatment LM Juárez-Salcedo, L Sokol, JC Chavez, S Dalia Cancer Control 25 (1), 1073274818778256, 2018 | 136 | 2018 |
| Venetoclax: evidence to date and clinical potential LM Juárez-Salcedo, V Desai, S Dalia Drugs in context 8, 2019 | 114 | 2019 |
| The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: the future is now LM Juárez-Salcedo, J Sandoval-Sus, L Sokol, JC Chavez, S Dalia Critical reviews in oncology/hematology 113, 52-62, 2017 | 31 | 2017 |
| Lymphoplasmacytic lymphoma and marginal zone lymphoma LM Juárez-Salcedo, JJ Castillo Hematology/Oncology Clinics 33 (4), 639-656, 2019 | 17 | 2019 |
| Management of adverse effects of new monoclonal antibody treatments in acute lymphoblastic leukemia D Conde-Royo, LM Juárez-Salcedo, S Dalia Drugs in Context 9, 2020 | 7 | 2020 |
| Use of anti-CD20 therapy in follicular and marginal zone lymphoma: a review of the literature LM Juárez-Salcedo, D Conde-Royo, K Quiroz-Cervantes, S Dalia Drugs in Context 9, 2020 | 7 | 2020 |
| Acquired elliptocytosis in a patient with a myelodysplastic syndrome associated with 20q deletion. KS Quiroz‐Cervantes, LM Juárez‐Salcedo, I Nuevo, H Guillen, J Arbeteta, ... British Journal of Haematology 185 (2), 2019 | 4 | 2019 |
| Castleman’s disease J Salcedo, S Dalia Atlas Genet Cytogenet Oncol Haematol 22 (3), 101-103, 2018 | 3 | 2018 |
| Successful long-term use of eltrombopag in a patient with refractory severe thrombocytopenia associated with chronic lymphocytic leukemia that allowed oral anticoagulant … JS Luis Miguel, GF Juan José Case Reports in Hematology 2017, 2017 | 3 | 2017 |
| Indolent non-Hodgkin lymphoma treatment in the new drugs era LM Juárez-Salcedo, S Dalia Chinese Clinical Oncology 9 (6), 81-81, 2020 | 2 | 2020 |
| Fibroblastic reticular cell tumor CR Diego, M Luis, D Samir Atlas Genet Cytogenet Oncol Haematol 24 (3), 140-1, 2020 | 2 | 2020 |
| Interdigitating dendritic cell sarcoma CR Diego, MJS Luis, D Samir Atlas Genet Cytogenet Oncol Haematol 23 (10), 317-19, 2019 | 2 | 2019 |
| Del (13q) in chronic lymphocytic leukemia LM Juárez-Salcedo, D Samir Atlas Genet Cytogenet Oncol Haematol 21, 292-293, 2017 | 2 | 2017 |
| Adverse events of radioimmunotherapy for non-Hodgkin lymphoma: A systematic review and meta-analysis E Sharda, RS Patel, LM Juárez-Salcedo, S Dalia, CH Hanna, H Gruhonjic, ... Leukemia Research 108, 106615, 2021 | 1 | 2021 |
| Immunotherapy for diffuse large B-cell lymphoma: current use of immune checkpoint inhibitors therapy. L Miguel Juárez-Salcedo, L Manuel González, S Dalia AIMS Medical Science 10 (3), 2023 | | 2023 |
| Neutropenia secondary to SARS-Cov2 vaccination in post-hematopoietic stem cell transplant (HSCT) patients LM Juárez-Salcedo, SF Monroy, C García-Herce, A Alonso, B Aguado, ... Mediterranean Journal of Hematology and Infectious Diseases 15 (1), 2023 | | 2023 |
| The Role of Prophylactic Chemotherapy for the Prevention of Central Nervous System Relapse in Patients with Large B Cell Lymphoma: A Meta-Analysis L Juarez-Salcedo, N Ianniello, E Coughlin, JC Chavez, J Sandoval-Sus, ... Blood 140 (Supplement 1), 3825-3826, 2022 | | 2022 |
| Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021 A Alegre, L Juarez-Salcedo, V Jiménez-Yuste, J Garcia-Suarez, ... Blood 140 (Supplement 1), 10965-10966, 2022 | | 2022 |
| Leukaemia Section DC Royo, LMJ Salcedo, S Dalia | | 2020 |
| Primary Cutaneous CD8 Aggressive Epidermotropic Cytotoxic T Cell Lymphoma AM Corazón-Monzón, LM Juárez-Salcedo, S Dalia Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2020 | | 2020 |
